Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Código de la empresaALUR_t
Nombre de la empresaAllurion Technologies Inc
Fecha de salida a bolsaMar 29, 2021
Fundada en2023
Director ejecutivoDr. Shantanu Gaur, M.D.
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección11 Huron Dr Ste 200
CiudadNATICK
Bolsa de valores- -
PaísUnited States of America
Código postal01760
Teléfono15086474000
Sitio Webhttps://www.allurion.com/en
Código de la empresaALUR_t
Fecha de salida a bolsaMar 29, 2021
Fundada en2023
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos